echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The "Medical Security Law" is coming soon!

    The "Medical Security Law" is coming soon!

    • Last Update: 2021-06-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Medical Network News on June 17 
     
    Another medical insurance law/law is about to come out!
     
    On June 15, the National Medical Insurance Administration issued an announcement on the "Medical Security Law (Draft for Solicitation of Comments)", which contained eight chapters and 70 articles, which improved the guarantee methods, operating mechanisms and functions of China’s basic medical insurance system from various aspects.
    Management methods
    .
     
    As early as August 28 last year, the National Medical Insurance Bureau published on its official website the “Response to Recommendation No.
    5326 of the Third Session of the Thirteenth National People’s Congress”.
    The bureau is actively promoting the legislative work of the "Medical Security Law" to effectively respond to the expectations of all sectors of the society for the construction of the legal system for medical security
    .
     
    After 30 years of development, China has now formed a multi-level medical security system.
    However, due to various reasons, China's medical security legislation lags behind the development of medical security
    .
    So far, no laws or regulations on medical insurance have been formulated at the national level, and relevant regulations on medical insurance are scattered in various regulatory documents, which are not conducive to the advancement of medical insurance in accordance with the law.
    Therefore, a top-level legal system is urgently needed to restrict it.
    Guarantee the development of medical insurance
    .

     
    Now, this rule of law will also be promulgated
    .
    Let's take a look at the content related to pharmaceutical companies and recruitment agencies
    .

     
    Centralized procurement of pharmaceuticals and consumables, medical institutions purchase on the platform, and encourage non-public hospitals to participate in centralized procurement
     
    The state establishes a centralized procurement system for medicines and medical consumables in public medical institutions
    .
    The medical security administrative department formulates and supervises the implementation of bidding procurement policies for drugs and medical consumables , and guides the construction of a centralized procurement platform for drugs and medical consumables
    .

     
    The provincial medical insurance administrative department organizes public medical institutions within its jurisdiction to carry out centralized procurement of medicines and medical consumables and supervises the implementation.
    The centralized procurement platform is established in accordance with the unified planning and standards of the medical insurance administrative department of the State Council, and the provincial centralized procurement agency is responsible for management
    .
     
    Provincial centralized procurement agencies shall implement the transaction rules and standards formulated by the medical security administrative department, carry out the bidding, procurement, trading, and settlement of drugs and medical consumables, and monitor relevant information
    .
    Public medical institutions shall purchase necessary drugs and medical consumables from the provincial centralized procurement platform in accordance with regulations
    .

     
    The state encourages non-public medical institutions to participate in the centralized procurement of medicines and medical consumables
    .
     
    Pharmaceutical companies are not allowed to bid at a price lower than the cost, and the medical insurance department will conduct a survey on the cost of drugs and medical consumables
     
    Participate in the bidding of the pharmaceutical companies should follow fair, lawful and good faith, consistent with the principles of quality and price, reasonably priced, not price below cost bid, not fraud, bid-rigging, abuse of dominant market position, etc.
    bid
    .
    Pharmaceutical companies that have won the bid shall ensure the safety, effectiveness and quality controllability of drugs and medical consumables, sign purchase and sale agreements in a timely manner, and ensure the supply and distribution in place in accordance with the requirements of the purchase and sale agreement
    .

     
      Medical institutions should make timely payments in accordance with the purchase and sale agreement, and encourage the medical security fund to settle directly with pharmaceutical companies
    .
     
      Government-guided prices are applied for basic medical services provided by public medical institutions, and market-adjusted prices are applied for non-basic medical services such as special needs
    .
    Medical services provided by non-public medical institutions are subject to market-adjusted prices
    .
    The prices of medicines and medical consumables with market-adjusted prices in accordance with the law, as well as medical services, shall be set in accordance with the principles of fairness, legality, quality and price, and honesty and trustworthiness
    .
     
      Medical institutions shall publicize the prices of medicines, medical consumables and medical services in a clear and clear manner, strengthen the management of the rational use of medicines and medical consumables, truthfully issue expense receipts and related materials, and accept price monitoring, guidance, inspection and cost from medical security and other departments Investigate
    .
     
      The medical security administrative department is responsible for conducting cost price surveys of drugs and medical consumables, implementing a credit evaluation system for drug prices and bidding purchases, and strengthening supervision and inspection of illegal acts infringing on the medical security fund by means of price monopoly and price bidding
    .
     
      The medical security administrative department shall establish a mechanism for macro-management, classified management, dynamic adjustment, monitoring and assessment of medical service prices, determine the procedures for setting and adjusting prices of medical services, and carry out medical service price monitoring, guidance, inspection, cost investigation and assessment for medical institutions
    .
     
      Relevant personnel are prohibited from seeking illegitimate benefits
     
      During the purchase and sale of drugs and medical consumables, pharmaceutical companies, medical institutions and their staff are prohibited from giving or receiving kickbacks or seeking other illegitimate benefits
    .
     
      Administrative departments such as medical security, medical security agencies, medical insurance premium collection departments, designated medical institutions and their staff shall not accept bribes or obtain other illegal income
    .
     
      The penalties for recruitment violations are further clarified and strengthened
     
      If a centralized procurement agency has one of the following circumstances, the medical security administrative department shall order corrections, and the directly responsible persons in charge and other directly responsible persons shall be punished according to law; if the medical security fund is lost, it shall be ordered to be returned; if it violates other laws and administrative regulations , To be punished by the relevant competent authorities in accordance with the law:
     
       (1) Failing to implement transaction rules and standards such as listing and withdrawal of the centralized procurement platform;
     
       (2) Abusing the power of centralized procurement, restricting market competition or causing unfair competition;
     
       (3) Seeking illegitimate benefits in the process of centralized procurement;
     
       (4) Other illegal acts in the process of centralized procurement
    .
     
      If a pharmaceutical company has one of the following circumstances, the medical security administrative department shall order it to make corrections and confiscate the illegal gains; if the bid is won, the bid won is invalid, and a fine of 5‰ to 10‰ of the amount of the winning project shall be imposed; the legal representative, the main person in charge, and the direct The responsible person in charge and other responsible persons shall impose a fine of 5% or more and less than 10% of the fine of the unit; if the circumstances are serious, restrict or suspend the qualification of relevant pharmaceutical companies or relevant drugs and medical consumables to participate in centralized procurement and make an announcement; violate other laws In case of administrative regulations, the relevant competent departments shall impose penalties in accordance with the law:
     
       (1) Bidding at a price lower than the cost, or bidding through fraud, bid collusion, abuse of market dominance, etc.
    ;
     
       (2) Offering bribes to medical security agencies, centralized procurement agencies, designated medical institutions and their staff;
     
       (3) After winning the bid, waive the qualification for selection without proper reason, fail to sign the purchase and sale agreement in time, fail to fulfill the supply promise, fail to supply the goods in accordance with the agreement and relevant laws and regulations;
     
       (4) Other illegal acts in the bidding process
    .
     
    Penalties for violations of   designated pharmacies have also been clarified
     
      If the designated medical institution has not established an internal management system for the medical security fund, or failed to interface with the medical security information system in accordance with the regulations, the medical security administrative department shall order corrections and may interview the relevant persons in charge; if they refuse to make corrections, they shall be punished.
    A fine of not less than 10,000 yuan but not more than 50,000 yuan; violations of other laws and administrative regulations shall be dealt with by the relevant competent authorities in accordance with the law
    .
     
      If a designated medical institution has irregular use of the medical security fund, the medical security administrative department shall order it to make corrections, and may interview the relevant person in charge; if the medical security fund is damaged, it shall be ordered to be returned, and the amount of damage caused is more than 1 time and less than 2 times.
    Fines; if it refuses to make corrections or causes serious consequences, the designated medical institution shall be ordered to suspend the medical services used by the medical security fund for 6 months to 1 year by the relevant responsible department; violations of other laws and administrative regulations shall be dealt with by the relevant competent authorities in accordance with the law
    .
     
      If the designated medical institution and its staff defraud the medical security fund expenditure, the medical security administrative department shall order the refund and impose a fine of 2 times to 5 times of the fraudulent amount; order the designated medical institution to suspend the relevant responsible department for 6 months to 1 year.
    Medical services used by the medical security fund until the service agreement is terminated by the medical security agency; if there is a qualification, the relevant competent authority shall revoke the qualification in accordance with the law
    .
     
      If a designated medical institution violates the provisions of this law and causes major losses to the medical security fund or other serious adverse social impacts, the medical security administrative department shall impose on its legal representative or main person in charge the previous year’s 50% or more of the income from the unit and 1 time The following fines shall be prohibited from engaging in management activities of designated medical institutions within 5 years, and shall be punished by relevant departments in accordance with the law
    .
    Medical Network News on June 17 
     
      Another medical insurance law/law is about to come out!
     
      On June 15, the National Medical Insurance Administration issued an announcement on the "Medical Security Law (Draft for Solicitation of Comments)", which contained eight chapters and 70 articles, which improved the guarantee methods, operating mechanisms and functions of China’s basic medical insurance system from various aspects.
    Management methods
    .
     
      As early as August 28 last year, the National Medical Insurance Bureau published on its official website the “Response to Recommendation No.
    5326 of the Third Session of the Thirteenth National People’s Congress”.
    The bureau is actively promoting the legislative work of the "Medical Security Law" to effectively respond to the expectations of all sectors of the society for the construction of the legal system for medical security
    .
     
      After 30 years of development, China has now formed a multi-level medical security system.
    However, due to various reasons, China's medical security legislation lags behind the development of medical security
    .
    So far, no laws or regulations on medical insurance have been formulated at the national level, and relevant regulations on medical insurance are scattered in various regulatory documents, which are not conducive to the advancement of medical insurance in accordance with the law.
    Therefore, a top-level legal system is urgently needed to restrict it.
    Guarantee the development of medical insurance
    .

     
      Now, this rule of law will also be promulgated
    .
    Let's take a look at the content related to pharmaceutical companies and recruitment agencies
    .

     
      Centralized procurement of pharmaceuticals and consumables, medical institutions purchase on the platform, and encourage non-public hospitals to participate in centralized procurement
     
      The state establishes a centralized procurement system for medicines and medical consumables in public medical institutions
    .
    The medical security administrative department formulates and supervises the implementation of bidding procurement policies for drugs and medical consumables , and guides the construction of a centralized procurement platform for drugs and medical consumables
    .

     
      The provincial medical insurance administrative department organizes public medical institutions within its jurisdiction to carry out centralized procurement of medicines and medical consumables and supervises the implementation.
    The centralized procurement platform is established in accordance with the unified planning and standards of the medical insurance administrative department of the State Council, and the provincial centralized procurement agency is responsible for management
    .
     
      Provincial centralized procurement agencies shall implement the transaction rules and standards formulated by the medical security administrative department, carry out the bidding, procurement, trading, and settlement of drugs and medical consumables, and monitor relevant information
    .
    Public medical institutions shall purchase necessary drugs and medical consumables from the provincial centralized procurement platform in accordance with regulations
    .

     
      The state encourages non-public medical institutions to participate in the centralized procurement of medicines and medical consumables
    .
     
      Pharmaceutical companies are not allowed to bid at a price lower than the cost, and the medical insurance department will conduct a survey on the cost of drugs and medical consumables
     
      Participate in the bidding of the pharmaceutical companies should follow fair, lawful and good faith, consistent with the principles of quality and price, reasonably priced, not price below cost bid, not fraud, bid-rigging, abuse of dominant market position, etc.
    bid
    .
    Pharmaceutical companies that have won the bid shall ensure the safety, effectiveness and quality controllability of drugs and medical consumables, sign purchase and sale agreements in a timely manner, and ensure the supply and distribution in place in accordance with the requirements of the purchase and sale agreement
    .

     
      Medical institutions should make timely payments in accordance with the purchase and sale agreement, and encourage the medical security fund to settle directly with pharmaceutical companies
    .
     
      Government-guided prices are applied for basic medical services provided by public medical institutions, and market-adjusted prices are applied for non-basic medical services such as special needs
    .
    Medical services provided by non-public medical institutions are subject to market-adjusted prices
    .
    The prices of medicines and medical consumables with market-adjusted prices in accordance with the law, as well as medical services, shall be set in accordance with the principles of fairness, legality, quality and price, and honesty and trustworthiness
    .
     
      Medical institutions shall publicize the prices of medicines, medical consumables and medical services in a clear and clear manner, strengthen the management of the rational use of medicines and medical consumables, truthfully issue expense receipts and related materials, and accept price monitoring, guidance, inspection and cost from medical security and other departments Investigate
    .
     
      The medical security administrative department is responsible for conducting cost price surveys of drugs and medical consumables, implementing a credit evaluation system for drug prices and bidding purchases, and strengthening supervision and inspection of illegal acts infringing on the medical security fund by means of price monopoly and price bidding
    .
     
      The medical security administrative department shall establish a mechanism for macro-management, classified management, dynamic adjustment, monitoring and assessment of medical service prices, determine the procedures for setting and adjusting prices of medical services, and carry out medical service price monitoring, guidance, inspection, cost investigation and assessment for medical institutions
    .
     
      Relevant personnel are prohibited from seeking illegitimate benefits
     
      During the purchase and sale of drugs and medical consumables, pharmaceutical companies, medical institutions and their staff are prohibited from giving or receiving kickbacks or seeking other illegitimate benefits
    .
     
      Administrative departments such as medical security, medical security agencies, medical insurance premium collection departments, designated medical institutions and their staff shall not accept bribes or obtain other illegal income
    .
     
      The penalties for recruitment violations are further clarified and strengthened
     
      If a centralized procurement agency has one of the following circumstances, the medical security administrative department shall order corrections, and the directly responsible persons in charge and other directly responsible persons shall be punished according to law; if the medical security fund is lost, it shall be ordered to be returned; if it violates other laws and administrative regulations , To be punished by the relevant competent authorities in accordance with the law:
     
       (1) Failing to implement transaction rules and standards such as listing and withdrawal of the centralized procurement platform;
     
       (2) Abusing the power of centralized procurement, restricting market competition or causing unfair competition;
     
       (3) Seeking illegitimate benefits in the process of centralized procurement;
     
       (4) Other illegal acts in the process of centralized procurement
    .
     
      If a pharmaceutical company has one of the following circumstances, the medical security administrative department shall order it to make corrections and confiscate the illegal gains; if the bid is won, the bid won is invalid, and a fine of 5‰ to 10‰ of the amount of the winning project shall be imposed; the legal representative, the main person in charge, and the direct The responsible person in charge and other responsible persons shall impose a fine of 5% or more and less than 10% of the fine of the unit; if the circumstances are serious, restrict or suspend the qualification of relevant pharmaceutical companies or relevant drugs and medical consumables to participate in centralized procurement and make an announcement; violate other laws In case of administrative regulations, the relevant competent departments shall impose penalties in accordance with the law:
     
       (1) Bidding at a price lower than the cost, or bidding through fraud, bid collusion, abuse of market dominance, etc.
    ;
     
       (2) Offering bribes to medical security agencies, centralized procurement agencies, designated medical institutions and their staff;
     
       (3) After winning the bid, waive the qualification for selection without proper reason, fail to sign the purchase and sale agreement in time, fail to fulfill the supply promise, fail to supply the goods in accordance with the agreement and relevant laws and regulations;
     
       (4) Other illegal acts in the bidding process
    .
     
    Penalties for violations of   designated pharmacies have also been clarified
     
      If the designated medical institution has not established an internal management system for the medical security fund, or failed to interface with the medical security information system in accordance with the regulations, the medical security administrative department shall order corrections and may interview the relevant persons in charge; if they refuse to make corrections, they shall be punished.
    A fine of not less than 10,000 yuan but not more than 50,000 yuan; violations of other laws and administrative regulations shall be dealt with by the relevant competent authorities in accordance with the law
    .
     
      If a designated medical institution has irregular use of the medical security fund, the medical security administrative department shall order it to make corrections, and may interview the relevant person in charge; if the medical security fund is damaged, it shall be ordered to be returned, and the amount of damage caused is more than 1 time and less than 2 times.
    Fines; if it refuses to make corrections or causes serious consequences, the designated medical institution shall be ordered to suspend the medical services used by the medical security fund for 6 months to 1 year by the relevant responsible department; violations of other laws and administrative regulations shall be dealt with by the relevant competent authorities in accordance with the law
    .
     
      If the designated medical institution and its staff defraud the medical security fund expenditure, the medical security administrative department shall order the refund and impose a fine of 2 times to 5 times of the fraudulent amount; order the designated medical institution to suspend the relevant responsible department for 6 months to 1 year.
    Medical services used by the medical security fund until the service agreement is terminated by the medical security agency; if there is a qualification, the relevant competent authority shall revoke the qualification in accordance with the law
    .
     
      If a designated medical institution violates the provisions of this law and causes major losses to the medical security fund or other serious adverse social impacts, the medical security administrative department shall impose on its legal representative or main person in charge the previous year’s 50% or more of the income from the unit and 1 time The following fines shall be prohibited from engaging in management activities of designated medical institutions within 5 years, and shall be punished by relevant departments in accordance with the law
    .
    Medical Network News on June 17 
     
      Another medical insurance law/law is about to come out!
      Another medical insurance law/law is about to come out!
     
      On June 15, the National Medical Insurance Administration issued an announcement on the "Medical Security Law (Draft for Solicitation of Comments)", which contained eight chapters and 70 articles, which improved the guarantee methods, operating mechanisms and functions of China’s basic medical insurance system from various aspects.
    Management methods
    .
     
      As early as August 28 last year, the National Medical Insurance Bureau published on its official website the “Response to Recommendation No.
    5326 of the Third Session of the Thirteenth National People’s Congress”.
    The bureau is actively promoting the legislative work of the "Medical Security Law" to effectively respond to the expectations of all sectors of the society for the construction of the legal system for medical security
    .
     
      After 30 years of development, China has now formed a multi-level medical security system.
    However, due to various reasons, China's medical security legislation lags behind the development of medical security
    .
    So far, no laws or regulations on medical insurance have been formulated at the national level, and relevant regulations on medical insurance are scattered in various regulatory documents, which are not conducive to the advancement of medical insurance in accordance with the law.
    Therefore, a top-level legal system is urgently needed to restrict it.
    Guarantee the development of medical insurance
    .

     
      Now, this rule of law will also be promulgated
    .
    Let's take a look at the content related to pharmaceutical companies and recruitment agencies
    .

     
      Centralized procurement of pharmaceuticals and consumables, medical institutions purchase on the platform, and encourage non-public hospitals to participate in centralized procurement
      Centralized procurement of pharmaceuticals and consumables, medical institutions purchase on the platform, and encourage non-public hospitals to participate in centralized procurement
     
      The state establishes a centralized procurement system for medicines and medical consumables in public medical institutions
    .
    The medical security administrative department formulates and supervises the implementation of bidding procurement policies for drugs and medical consumables , and guides the construction of a centralized procurement platform for drugs and medical consumables
    .

    Drugs Drugs Drugs Tender Tender Tender
     
      The provincial medical insurance administrative department organizes public medical institutions within its jurisdiction to carry out centralized procurement of medicines and medical consumables and supervises the implementation.
    The centralized procurement platform is established in accordance with the unified planning and standards of the medical insurance administrative department of the State Council, and the provincial centralized procurement agency is responsible for management
    .
     
      Provincial centralized procurement agencies shall implement the transaction rules and standards formulated by the medical security administrative department, carry out the bidding, procurement, trading, and settlement of drugs and medical consumables, and monitor relevant information
    .
    Public medical institutions shall purchase necessary drugs and medical consumables from the provincial centralized procurement platform in accordance with regulations
    .

     
      The state encourages non-public medical institutions to participate in the centralized procurement of medicines and medical consumables
    .
     
      Pharmaceutical companies are not allowed to bid at a price lower than the cost, and the medical insurance department will conduct a survey on the cost of drugs and medical consumables
      Pharmaceutical companies are not allowed to bid at a price lower than the cost, and the medical insurance department will conduct a survey on the cost of drugs and medical consumables
     
      Participate in the bidding of the pharmaceutical companies should follow fair, lawful and good faith, consistent with the principles of quality and price, reasonably priced, not price below cost bid, not fraud, bid-rigging, abuse of dominant market position, etc.
    bid
    .
    Pharmaceutical companies that have won the bid shall ensure the safety, effectiveness and quality controllability of drugs and medical consumables, sign purchase and sale agreements in a timely manner, and ensure the supply and distribution in place in accordance with the requirements of the purchase and sale agreement
    .

    Pharmaceutical companies Pharmaceutical pharmaceutical business enterprises
     
      Medical institutions should make timely payments in accordance with the purchase and sale agreement, and encourage the medical security fund to settle directly with pharmaceutical companies
    .
     
      Government-guided prices are applied for basic medical services provided by public medical institutions, and market-adjusted prices are applied for non-basic medical services such as special needs
    .
    Medical services provided by non-public medical institutions are subject to market-adjusted prices
    .
    The prices of medicines and medical consumables with market-adjusted prices in accordance with the law, as well as medical services, shall be set in accordance with the principles of fairness, legality, quality and price, and honesty and trustworthiness
    .
     
      Medical institutions shall publicize the prices of medicines, medical consumables and medical services in a clear and clear manner, strengthen the management of the rational use of medicines and medical consumables, truthfully issue expense receipts and related materials, and accept price monitoring, guidance, inspection and cost from medical security and other departments Investigate
    .
     
      The medical security administrative department is responsible for conducting cost price surveys of drugs and medical consumables, implementing a credit evaluation system for drug prices and bidding purchases, and strengthening supervision and inspection of illegal acts infringing on the medical security fund by means of price monopoly and price bidding
    .
     
      The medical security administrative department shall establish a mechanism for macro-management, classified management, dynamic adjustment, monitoring and assessment of medical service prices, determine the procedures for setting and adjusting prices of medical services, and carry out medical service price monitoring, guidance, inspection, cost investigation and assessment for medical institutions
    .
     
      Relevant personnel are prohibited from seeking illegitimate benefits
      Relevant personnel are prohibited from seeking illegitimate benefits
     
      During the purchase and sale of drugs and medical consumables, pharmaceutical companies, medical institutions and their staff are prohibited from giving or receiving kickbacks or seeking other illegitimate benefits
    .
     
      Administrative departments such as medical security, medical security agencies, medical insurance premium collection departments, designated medical institutions and their staff shall not accept bribes or obtain other illegal income
    .
     
      The penalties for recruitment violations are further clarified and strengthened
      The penalties for recruitment violations are further clarified and strengthened
     
      If a centralized procurement agency has one of the following circumstances, the medical security administrative department shall order corrections, and the directly responsible persons in charge and other directly responsible persons shall be punished according to law; if the medical security fund is lost, it shall be ordered to be returned; if it violates other laws and administrative regulations , To be punished by the relevant competent authorities in accordance with the law:
     
       (1) Failing to implement transaction rules and standards such as listing and withdrawal of the centralized procurement platform;
     
       (2) Abusing the power of centralized procurement, restricting market competition or causing unfair competition;
     
       (3) Seeking illegitimate benefits in the process of centralized procurement;
     
       (4) Other illegal acts in the process of centralized procurement
    .
     
      If a pharmaceutical company has one of the following circumstances, the medical security administrative department shall order it to make corrections and confiscate the illegal gains; if the bid is won, the bid won is invalid, and a fine of 5‰ to 10‰ of the amount of the winning project shall be imposed; the legal representative, the main person in charge, and the direct The responsible person in charge and other responsible persons shall impose a fine of 5% or more and less than 10% of the fine of the unit; if the circumstances are serious, restrict or suspend the qualification of relevant pharmaceutical companies or relevant drugs and medical consumables to participate in centralized procurement and make an announcement; violate other laws In case of administrative regulations, the relevant competent departments shall impose penalties in accordance with the law:
     
       (1) Bidding at a price lower than the cost, or bidding through fraud, bid collusion, abuse of market dominance, etc.
    ;
     
       (2) Offering bribes to medical security agencies, centralized procurement agencies, designated medical institutions and their staff;
     
       (3) After winning the bid, waive the qualification for selection without proper reason, fail to sign the purchase and sale agreement in time, fail to fulfill the supply promise, fail to supply the goods in accordance with the agreement and relevant laws and regulations;
     
       (4) Other illegal acts in the bidding process
    .
     
    Penalties for violations of   designated pharmacies have also been clarified
      Designated pharmacies pharmacies pharmacies violation penalties are expressly
     
      If the designated medical institution has not established an internal management system for the medical security fund, or failed to interface with the medical security information system in accordance with the regulations, the medical security administrative department shall order corrections and may interview the relevant persons in charge; if they refuse to make corrections, they shall be punished.
    A fine of not less than 10,000 yuan but not more than 50,000 yuan; violations of other laws and administrative regulations shall be dealt with by the relevant competent authorities in accordance with the law
    .
     
      If a designated medical institution has irregular use of the medical security fund, the medical security administrative department shall order it to make corrections, and may interview the relevant person in charge; if the medical security fund is damaged, it shall be ordered to be returned, and the amount of damage caused is more than 1 time and less than 2 times.
    Fines; if it refuses to make corrections or causes serious consequences, the designated medical institution shall be ordered to suspend the medical services used by the medical security fund for 6 months to 1 year by the relevant responsible department; violations of other laws and administrative regulations shall be dealt with by the relevant competent authorities in accordance with the law
    .
     
      If the designated medical institution and its staff defraud the medical security fund expenditure, the medical security administrative department shall order the refund and impose a fine of 2 times to 5 times of the fraudulent amount; order the designated medical institution to suspend the relevant responsible department for 6 months to 1 year.
    Medical services used by the medical security fund until the service agreement is terminated by the medical security agency; if there is a qualification, the relevant competent authority shall revoke the qualification in accordance with the law
    .
     
      If a designated medical institution violates the provisions of this law and causes major losses to the medical security fund or other serious adverse social impacts, the medical security administrative department shall impose on its legal representative or main person in charge the previous year’s 50% or more of the income from the unit and 1 time The following fines shall be prohibited from engaging in management activities of designated medical institutions within 5 years, and shall be punished by relevant departments in accordance with the law
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.